Hina Rehman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hina Rehman has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Amber Nawab
Sindh Medical College, Jinnah Sindh Medical University, Karachi
1 shared publication - Ambreen Qamar
Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan
1 shared publication Anam Tariq
Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi
1 shared publication- Anees Ur Rehman
Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
1 shared publication Fareeha Butt
Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan
1 shared publicationFarya Zafar
Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi
1 shared publication
Latest Publications
- Open Access
- 4 November 2022
- Published by Advanced Research Publications in JOURNAL OF ADVANCED RESEARCH IN AYURVEDA, YOGA, UNANI, SIDHHA & HOMEOPATHY
- Vol. 09 (3&4) , 1-5
Management of Recurrent Tinea Corporis by Unani Medicine: A Report on Case Studies
Dermatophytosis or Tinea infection is a common skin problem frequently encountered in general practice. Although several antifungal drugs are prescribed for complete eradication of the stubborn contagious infection, some species are reciprocators to these antifungal agents which causes a rise in the number of resistant Tinea infections. Recurrent Tinea Corporis (RTC) is becoming an emerging problem nowadays. The present case report is a compilation of two diagnosed cases of RTC of more than 9 months. These two cases were treated in the OPD of the National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD), Hyderabad with classic principles of Unani by Itrifal Shahtara (Polyherbal Unani Formulation) for oral intake and Marham Kharish Jadeed as a local application over a period of 12 weeks with regular follow-ups for assessment of symptoms. After 12 weeks of therapy, complete resolution in the first case and markedly resolution in the second case; in the number of lesions, severity of itching and erythema is observed. In this study, the prescribed Unani Medicines have been efficiently managed due to their anti-inflammatory, antioxidant, free radical scavenging, analgesic and wound-healing properties. How to cite this article: Rehman H, Kazmi MH, Khadeerunnisa S. Management of Recurrent Tinea Corporis by Unani Medicine: A Report on Case Studies. J Adv Res Ayur Yoga Unani Sidd Homeo. 2022;9(3&4):1-5. DOI: https://doi.org/10.24321/2394.6547.202202
- 4 November 2022
- Published by Advanced Research Publications in JOURNAL OF ADVANCED RESEARCH IN AYURVEDA, YOGA, UNANI, SIDHHA & HOMEOPATHY
- Vol. 09 (3&4) , 1-5
Open AccessManagement of Recurrent Tinea Corporis by Unani Medicine: A Report on Case Studies
Dermatophytosis or Tinea infection is a common skin problem frequently encountered in general practice. Although several antifungal drugs are prescribed for complete eradication of the stubborn contagious infection, some species are reciprocators to these antifungal agents which causes a rise in the number of resistant Tinea infections. Recurrent Tinea Corporis (RTC) is becoming an emerging problem nowadays. The present case report is a compilation of two diagnosed cases of RTC of more than 9 months. These two cases were treated in the OPD of the National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD), Hyderabad with classic principles of Unani by Itrifal Shahtara (Polyherbal Unani Formulation) for oral intake and Marham Kharish Jadeed as a local application over a period of 12 weeks with regular follow-ups for assessment of symptoms. After 12 weeks of therapy, complete resolution in the first case and markedly resolution in the second case; in the number of lesions, severity of itching and erythema is observed. In this study, the prescribed Unani Medicines have been efficiently managed due to their anti-inflammatory, antioxidant, free radical scavenging, analgesic and wound-healing properties. How to cite this article: Rehman H, Kazmi MH, Khadeerunnisa S. Management of Recurrent Tinea Corporis by Unani Medicine: A Report on Case Studies. J Adv Res Ayur Yoga Unani Sidd Homeo. 2022;9(3&4):1-5. DOI: https://doi.org/10.24321/2394.6547.202202
- Open Access
- 24 March 2022
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 10, 829339
Assessment of Knowledge, Attitude, and Practice of Obstetricians and Gynecologists Toward Off-Label Medicine Use in Female Reproductive Health Issues
Background: Off-label medication usage (OLMU) is prevalent in the treatment of various diseases, including female reproductive health issues (FRHIs). However, there is a paucity of literature on the perspective of health professionals on this subject. The purpose of the current study was to assess gynecologists/obstetricians' knowledge, attitude and practice toward OLMU in the treatment of FRHIs.Methods: The current cross-sectional study was conducted in September and October 2021, at five tertiary care hospitals (two public and three private sector), different clinics and maternity homes in a metropolitan city of Karachi, Pakistan. The target population was gynecologists, obstetricians and physicians/residents working in the ob/gyn department in various hospitals and clinical settings of Karachi.Results: The overall response rate was 77.1%. The mean age of the study respondents was 36.1 ± 7.7 years; n = 85 (55.9%) respondents were working in primary patient care. The majorly reported OLMU by the respondents were clomiphene citrate in unexplained infertility (n = 66; 43.4%), metformin to improve cycle regularity in females with polycystic ovary syndrome (PCOS) (n = 59; 38.8%) and letrozole to induce ovulation (n = 31; 20.4%). The majorly stated categories of OLMU were at a different dose (n = 95; 62.5%) and at different indications than approved to treat (n = 89; 58.5%). It was reported by the majority of the respondents (n = 95; 62.5%) that they do not follow any guidelines or regulations for OLMU in their work setting; however, the response was statistically varied with the working organization (CI 2.14–2.93; p = 0.037) and practice area (CI 2.85–4.32; p = 0.0001) of respondents.Conclusions: The present study revealed that the respondents were well-familiar with the practice of OLMU in the treatment of FRHIs. They expressed their concerns about decreasing such practices by being involved in collective decision-making procedures, and they were inclined to accept initiatives aimed at ensuring drug safety in patients.
- 24 March 2022
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 10, 829339
Open AccessAssessment of Knowledge, Attitude, and Practice of Obstetricians and Gynecologists Toward Off-Label Medicine Use in Female Reproductive Health Issues
Background: Off-label medication usage (OLMU) is prevalent in the treatment of various diseases, including female reproductive health issues (FRHIs). However, there is a paucity of literature on the perspective of health professionals on this subject. The purpose of the current study was to assess gynecologists/obstetricians' knowledge, attitude and practice toward OLMU in the treatment of FRHIs.Methods: The current cross-sectional study was conducted in September and October 2021, at five tertiary care hospitals (two public and three private sector), different clinics and maternity homes in a metropolitan city of Karachi, Pakistan. The target population was gynecologists, obstetricians and physicians/residents working in the ob/gyn department in various hospitals and clinical settings of Karachi.Results: The overall response rate was 77.1%. The mean age of the study respondents was 36.1 ± 7.7 years; n = 85 (55.9%) respondents were working in primary patient care. The majorly reported OLMU by the respondents were clomiphene citrate in unexplained infertility (n = 66; 43.4%), metformin to improve cycle regularity in females with polycystic ovary syndrome (PCOS) (n = 59; 38.8%) and letrozole to induce ovulation (n = 31; 20.4%). The majorly stated categories of OLMU were at a different dose (n = 95; 62.5%) and at different indications than approved to treat (n = 89; 58.5%). It was reported by the majority of the respondents (n = 95; 62.5%) that they do not follow any guidelines or regulations for OLMU in their work setting; however, the response was statistically varied with the working organization (CI 2.14–2.93; p = 0.037) and practice area (CI 2.85–4.32; p = 0.0001) of respondents.Conclusions: The present study revealed that the respondents were well-familiar with the practice of OLMU in the treatment of FRHIs. They expressed their concerns about decreasing such practices by being involved in collective decision-making procedures, and they were inclined to accept initiatives aimed at ensuring drug safety in patients.
- Open Access
- 1 January 2020
- Published by Office of Research, Innovation and Commercialization, Iqra University in South Asian Journal of Management Sciences
- Vol. 14 (2) , 221-228
Career Counselling: Medical And Healthcare Students Perspective in Deciding their Career Preferences
South Asian Journal of Management Sciences (SAJMS) is a blind peer refereed journal published bi-annually by Iqra University. The journal recognizes growing involvement of regional issues in management sciences within the larger context of globalization and international arena.
- 1 January 2020
- Published by Office of Research, Innovation and Commercialization, Iqra University in South Asian Journal of Management Sciences
- Vol. 14 (2) , 221-228
Open AccessCareer Counselling: Medical And Healthcare Students Perspective in Deciding their Career Preferences
South Asian Journal of Management Sciences (SAJMS) is a blind peer refereed journal published bi-annually by Iqra University. The journal recognizes growing involvement of regional issues in management sciences within the larger context of globalization and international arena.
- 31 October 2014
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 12 (1) , 61-69
Effect of rhubarb ( Rheum emodi ) in primary dysmenorrhoea: a single-blind randomized controlled trial
Background : The aim of this study was to investigate and evaluate the efficacy of Rheum emodi in the management of primary dysmenorrhoea. Methods : A randomized, single-blind, standard controlled trial compared efficacy of R. emodi against mefenamic acid on diagnosed subjects of primary dysmenorrhoea for three consecutive cycles. Experimental group (n=30) received capsules of R. emodi powder two times a day, two days before the expected date of menstruation, and continued first three days of menstruation, while control group (n=15) participants received mefenamic acid capsules three times a day on the same protocol. The primary outcome measures were reduced in severity and duration of pain, assessed by visual analogue scale (VAS) and verbal multidimensional scoring system (VMSS), and secondary outcome measures were overall improvement of dysmenorrhoea and improved in quality of life (QOL). Statistical analysis was done by repeated measures analysis of variance and Chi-square/Fisher Exact test. Results : The menstrual pain was significantly decreased in both groups after three-cycle intervention. Significant changes were observed in VAS (pConclusions : It has been clear from the above result that R. emodi is an effective herb in alleviating symptoms of primary dysmenorrhoea. It can serve as an alternative treatment without any apparent side effects. These results deserve further investigations.
- 31 October 2014
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 12 (1) , 61-69
Effect of rhubarb ( Rheum emodi ) in primary dysmenorrhoea: a single-blind randomized controlled trial
Background : The aim of this study was to investigate and evaluate the efficacy of Rheum emodi in the management of primary dysmenorrhoea. Methods : A randomized, single-blind, standard controlled trial compared efficacy of R. emodi against mefenamic acid on diagnosed subjects of primary dysmenorrhoea for three consecutive cycles. Experimental group (n=30) received capsules of R. emodi powder two times a day, two days before the expected date of menstruation, and continued first three days of menstruation, while control group (n=15) participants received mefenamic acid capsules three times a day on the same protocol. The primary outcome measures were reduced in severity and duration of pain, assessed by visual analogue scale (VAS) and verbal multidimensional scoring system (VMSS), and secondary outcome measures were overall improvement of dysmenorrhoea and improved in quality of life (QOL). Statistical analysis was done by repeated measures analysis of variance and Chi-square/Fisher Exact test. Results : The menstrual pain was significantly decreased in both groups after three-cycle intervention. Significant changes were observed in VAS (pConclusions : It has been clear from the above result that R. emodi is an effective herb in alleviating symptoms of primary dysmenorrhoea. It can serve as an alternative treatment without any apparent side effects. These results deserve further investigations.